Top Midday Decliners

MT Newswires Live05-16

LanzaTech Global (LNZA) signed a securities purchase agreement with certain institutional investors to sell 2 million shares in a registered direct offering, targeting gross proceeds of about $20 million, the company said Friday.

Shares sank 43% following an increase in intraday trading volume to almost 323,000 from a daily average of over 44,000.

Aardvark Therapeutics (AARD) said the US Food and Drug Administration has placed a full clinical hold on its investigational new drug application for ARD-101, according to a company statement late Thursday.

Morgan Stanley downgraded the stock to underweight from equalweight, and BTIG to neutral from buy.

Shares of Aardvark slumped 31% as intraday trading volume advanced to more than 565,000 from a daily average of over 282,000.

York Space Systems (YSS) reported a Q1 loss of $114.8 million, compared with a loss of $11.7 million a year earlier.

Shares dropped 18%, with intraday trading volume at nearly 2.85 million, compared with a daily average of over 2.02 million.

Price: 9.74, Change: -7.41, Percent Change: -43.21

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2635343880?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-16 02:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2635343880","market":"nz","top_or_hot":-1,"title":"Top Midday Decliners","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/LNZA\">LanzaTech Global</a> (LNZA) signed a securities purchase agreement with certain institutional investors to sell 2 million shares in a registered direct offering, targeting gross proceeds of about $20 million, the company said Friday.</p><p>Shares sank 43% following an increase in intraday trading volume to almost 323,000 from a daily average of over 44,000.</p><p><a href=\"https://laohu8.com/S/AARD\">Aardvark Therapeutics</a> (AARD) said the US Food and Drug Administration has placed a full clinical hold on its investigational new drug application for ARD-101, according to a company statement late Thursday.</p><p>Morgan Stanley downgraded the stock to underweight from equalweight, and BTIG to neutral from buy.</p><p>Shares of Aardvark slumped 31% as intraday trading volume advanced to more than 565,000 from a daily average of over 282,000.</p><p>York Space Systems (YSS) reported a Q1 loss of $114.8 million, compared with a loss of $11.7 million a year earlier.</p><p>Shares dropped 18%, with intraday trading volume at nearly 2.85 million, compared with a daily average of over 2.02 million.</p><p>Price: 9.74, Change: -7.41, Percent Change: -43.21</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Decliners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Decliners\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-05-16 02:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/LNZA\">LanzaTech Global</a> (LNZA) signed a securities purchase agreement with certain institutional investors to sell 2 million shares in a registered direct offering, targeting gross proceeds of about $20 million, the company said Friday.</p><p>Shares sank 43% following an increase in intraday trading volume to almost 323,000 from a daily average of over 44,000.</p><p><a href=\"https://laohu8.com/S/AARD\">Aardvark Therapeutics</a> (AARD) said the US Food and Drug Administration has placed a full clinical hold on its investigational new drug application for ARD-101, according to a company statement late Thursday.</p><p>Morgan Stanley downgraded the stock to underweight from equalweight, and BTIG to neutral from buy.</p><p>Shares of Aardvark slumped 31% as intraday trading volume advanced to more than 565,000 from a daily average of over 282,000.</p><p>York Space Systems (YSS) reported a Q1 loss of $114.8 million, compared with a loss of $11.7 million a year earlier.</p><p>Shares dropped 18%, with intraday trading volume at nearly 2.85 million, compared with a daily average of over 2.02 million.</p><p>Price: 9.74, Change: -7.41, Percent Change: -43.21</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4187","symbol_name":"航天航空与国防","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2635343880","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2635343880","pubTimestamp":1778869228,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"LanzaTech Global  signed a securities purchase agreement with certain institutional investors to sell 2 million shares in a registered direct offering, targeting gross proceeds of about $20 million, the company said Friday.Shares sank 43% following an increase in intraday trading volume to almost 323,000 from a daily average of over 44,000.Aardvark Therapeutics  said the US Food and Drug Administration has placed a full clinical hold on its investigational new drug application for ARD-101, according to a company statement late Thursday.Morgan Stanley downgraded the stock to underweight from equalweight, and BTIG to neutral from buy.Shares of Aardvark slumped 31% as intraday trading volume advanced to more than 565,000 from a daily average of over 282,000.York Space Systems  reported a Q1 loss of $114.8 million, compared with a loss of $11.7 million a year earlier.Shares dropped 18%, with intraday trading volume at nearly 2.85 million, compared with a daily average of over 2.02 million.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4187":"航天航空与国防","BK4007":"制药","BK4120":"环境与设施服务","LNZA":"LanzaTech Global","YSS":"York Space Systems, Inc","AARD":"Aardvark Therapeutics"},"translate_title":"午盘跌幅最大的股票","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"YSS":1,"AARD":1,"LNZA":1},"content_text":"LanzaTech Global (LNZA) signed a securities purchase agreement with certain institutional investors to sell 2 million shares in a registered direct offering, targeting gross proceeds of about $20 million, the company said Friday.Shares sank 43% following an increase in intraday trading volume to almost 323,000 from a daily average of over 44,000.Aardvark Therapeutics (AARD) said the US Food and Drug Administration has placed a full clinical hold on its investigational new drug application for ARD-101, according to a company statement late Thursday.Morgan Stanley downgraded the stock to underweight from equalweight, and BTIG to neutral from buy.Shares of Aardvark slumped 31% as intraday trading volume advanced to more than 565,000 from a daily average of over 282,000.York Space Systems (YSS) reported a Q1 loss of $114.8 million, compared with a loss of $11.7 million a year earlier.Shares dropped 18%, with intraday trading volume at nearly 2.85 million, compared with a daily average of over 2.02 million.Price: 9.74, Change: -7.41, Percent Change: -43.21","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2635343880","isCrawlerRequest":true}